Think of Kimyrsa as Similar to Orbactiv
June 2021
Kimyrsa will be a new formulation of the IV antibiotic oritavancin.
Think of Kimyrsa as similar to the older product, Orbactiv. Each is given as a single dose...often to ED patients with certain skin infections...to help prevent or reduce hospital stays.
A big advantage is that Kimyrsa can be infused faster than Orbactiv...and potentially save time in the ED.
Practical advice for a better career, with unlimited access to CE
Hospital Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote